Akshay Vaishnaw, MD, PhD
Director
Dr. Vaishnaw is the Chief Innovation Officer at Alnylam Pharmaceuticals. Since joining the company in 2006, he has served in positions of increasing responsibility across Research and Development (R&D), and most recently as President of Alnylam. Prior to Alnylam, Dr. Vaishnaw was Senior Director, Translational Medicine at Biogen. Dr. Vaishnaw earned his bachelor’s degree from University College Cardiff, his MD from the University of Wales College of Medicine, and his PhD in Molecular Immunology from the University of London.
Meet the Team
Hemab unites experts in clotting, patient care, and drug development to transform the lives of people with bleeding disorders
